Sort
50,496 grants matching “lung cancer”
Role of Insulin Receptor Substrates in Kras-driven lung cancer
$404,888Nada Y. Kalaany · Boston Children'S Hospital · R01 · FY2017 · CA
The Role of Lung Resident Mesenchymal Stem Cells in Post-Chemotherapy Lung Metastases of Breast Cancer
$404,888Guangwen Ren · Jackson Laboratory · R37 · FY2025 · CA
Drivers of histologic transformation in EGFR-mutant lung cancer
$404,888Helena Yu · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma
$404,888Roberto Chiarle · Boston Children'S Hospital · R01 · FY2018 · CA
Targeting tumor endothelium for cancer surveillance and immunotherapy
$404,888Sonia Sharma · La Jolla Institute For Immunology · R01 · FY2016 · CA
Aptamer-siRNA gene knockdown to treat epithelial triple negative breast cancer
$404,888Judy Lieberman · Boston Children'S Hospital · R01 · FY2016 · CA
p190 RhoGAP signaling in epithelial oncogenesis
$404,888Steen Henning Hansen · Boston Children'S Hospital · R01 · FY2020 · CA
p190 RhoGAP signaling in epithelial oncogenesis
$404,888Steen Henning Hansen · Boston Children'S Hospital · R01 · FY2017 · CA
Targeting tumor endothelium for cancer surveillance and immunotherapy
$404,888Sonia Sharma · La Jolla Institute For Immunology · R01 · FY2017 · CA
Predicting sensitivity and resistance in RET-driven cancers
$404,888Alexander Drilon · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
APOBEC proteins as drivers of chromosomal translocations in solid cancers
$404,888Roberto Chiarle · Boston Children'S Hospital · R01 · FY2020 · CA
Aptamer-siRNA gene knockdown to treat epithelial triple negative breast cancer
$404,888Judy Lieberman · Boston Children'S Hospital · R01 · FY2017 · CA
Role of Insulin Receptor Substrates in Kras-driven lung cancer
$404,888Nada Y. Kalaany · Boston Children'S Hospital · R01 · FY2020 · CA
Role of Insulin Receptor Substrates in Kras-driven lung cancer
$404,888Nada Y. Kalaany · Boston Children'S Hospital · R01 · FY2021 · CA
p190 RhoGAP signaling in epithelial oncogenesis
$404,888Steen Henning Hansen · Boston Children'S Hospital · R01 · FY2021 · CA
Predicting sensitivity and resistance in RET-driven cancers
$404,888Alexander Drilon · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Regulation of the LIN28/let-7 pathway in cancer
$404,888Richard I. Gregory · Boston Children'S Hospital · R01 · FY2017 · CA
APOBEC proteins as drivers of chromosomal translocations in solid cancers
$404,888Roberto Chiarle · Boston Children'S Hospital · R01 · FY2018 · CA
Role of Insulin Receptor Substrates in Kras-driven lung cancer
$404,888Nada Y. Kalaany · Boston Children'S Hospital · R01 · FY2018 · CA
APOBEC proteins as drivers of chromosomal translocations in solid cancers
$404,888Roberto Chiarle · Boston Children'S Hospital · R01 · FY2021 · CA
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma
$404,888Roberto Chiarle · Boston Children'S Hospital · R01 · FY2016 · CA
Defining the impact of mutant oncogene zygosity
$404,888Sarat Chandarlapaty · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Defining the impact of mutant oncogene zygosity
$404,888Sarat Chandarlapaty · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma
$404,888Roberto Chiarle · Boston Children'S Hospital · R01 · FY2017 · CA
Targeting tumor endothelium for cancer surveillance and immunotherapy
$404,888Sonia Sharma · La Jolla Institute For Immunology · R01 · FY2018 · CA